Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05603897Recruiting
Testing dysphagia screening methods after recent stroke
This study compares two ways of checking for swallowing problems (dysphagia) in people who were recently hospitalized for an acute ischemic stroke. If the new screening method works better, it could help catch swallowing issues earlier and improve safety.
Miami, FloridaAges 18 years+ - NCT05607420RecruitingPhase 1/Phase 2
Testing a new cell therapy for relapsed lymphoma with CD20/CD22
This Phase 1/2 trial studies UCART20x22, a lab-made cell therapy, for people with certain types of relapsed or treatment-resistant B-cell non-Hodgkin lymphoma (NHL). It may help by targeting lymphoma cells that carry CD20 and/or CD22 markers and then testing safety and early effectiveness.
Chicago, IllinoisAges 18–80 - NCT05608681RecruitingPhase 1/Phase 2
Study drug for adults with eosinophilic esophagitis (EoE
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
Sydney, New South WalesAges 18–75 - NCT05610956RecruitingEarly Phase 1
Empagliflozin for mild-to-moderate ulcerative colitis
This early trial studies whether empagliflozin can improve ulcerative colitis symptoms and is safe for people with mild to moderate disease. If it works, it may reduce ongoing colon inflammation and help people feel better.
TantaAges 18–70 - NCT05613985Recruiting
Ultrasound light added to usual care for infected diabetic foot ulcers
This trial tests whether adding the VULNOFAST Plus/VULNOLIGHT system to usual care can heal infected diabetic foot ulcers more safely and effectively. It compares the added treatment plus usual care versus usual care alone.
ArezzoAges 18 years+ - NCT05616988Recruiting
Study body-image improvement after breast cancer surgery
This study looks at how body image changes after mastectomy and breast reconstruction, and whether certain body chemistry patterns (called metabolomics) are linked to that change. It may help researchers understand what supports better body-image recovery after breast cancer.
Rome, RomeAges 18 years+ - NCT05619185Recruiting
Online program to help couples reduce risky drinking
This study tests an adaptive (tailored) online program to help service members and their partners cut down risky alcohol use. It also focuses on whether couples can practice healthier communication and coping skills while feeling safe together.
Palo Alto, CaliforniaAges 18 years+ - NCT05620030Recruiting
Testing care plans for single-heart (univentricular) defects
This study follows people with a single-ventricle (univentricular) heart defect who need a multi-step treatment leading to the Fontan procedure. It aims to better understand how this staged care should be delivered and monitored over time.
ErlangenAges 6–60 - NCT05623514Recruiting
Ultrasound to better choose vNOTES surgery patients
This study looks at using an ultrasound scan to help doctors choose which patients may be good candidates for a type of vaginal surgery called vNOTES. It may help improve safety and outcomes by matching the right patients to the right approach.
Houston, TexasAges 18 years+ - NCT05626114RecruitingPhase 2
Study of a lab-made eye treatment after subretinal surgery
This Phase 2 study tests OpRegen, a treatment delivered during special eye surgery, for geographic atrophy related to age-related macular degeneration (GA from AMD). It also includes an imaging “substudy” that uses detailed pictures of your retina to better track safety and activity.
Beverly Hills, CaliforniaAges 50 years+ - NCT05628974Recruiting
Healthy adults can donate blood for platelet testing
This study looks at how platelets work and checks blood markers using donations from healthy volunteers. It may help researchers design future platelet-related treatments and better tests.
Cleveland, OhioAges 18–65 - NCT05629689RecruitingPhase 1
PET scan drug check for people with solid tumors
This Phase 1 study tests whether an investigational PET scan tracer is safe and tolerable when used for PET imaging in people with certain solid cancers. It mainly looks at side effects and how well the scan can be done, not whether it treats cancer.
AmsterdamAges 18 years+ - NCT05633706Recruiting
Testing a capsule to study gut bacteria in the small intestine
This study tests the SIMBA capsule to learn how gut bacteria (dysbiosis) relate to digestive conditions. It may help researchers better understand these conditions and how the capsule can be used safely.
Calgary, AlbertaAges 18–80 - NCT05636514RecruitingPhase 1
Testing epigenetic and sensitizer treatment for AML and MDS
This early-phase trial tests whether a combination of targeted medicines can improve outcomes in people with higher-risk MDS or certain types of AML or CMML. It’s designed to find the safest dose and learn if the treatment can help the cancer respond.
Sydney, New South WalesAges 18 years+ - NCT05636878Recruiting
Mobile mental health team for babies and toddlers
This study tests a mobile mental health support team for young children from birth to age 3. It may help families by bringing perinatal (around pregnancy and early parenting) psychiatric support closer to home.
LaxouAges 1 day–3 years - NCT05637086RecruitingPhase 2
Test pentoxifylline plus celecoxib for grand mal epilepsy on phenytoin
This Phase 2 study tests whether adding two medicines—pentoxifylline and celecoxib—to current phenytoin treatment is safe and may help people with grand mal (generalized) epilepsy. It focuses mainly on safety while you stay on a single epilepsy medicine.
Al MansurahAges 18–75 - NCT05638360RecruitingPhase 2
Test medicine for healing after wrist bone fracture surgery
This Phase 2 trial studies whether Ru-Yi-Jin-Huang-Saan (a traditional Chinese medicine) helps the wrist heal better after surgery for a Colles’ fracture. If you qualify, you may receive the medicine and be asked to complete questionnaires to track healing and outcomes.
Changhua, ChanghuaAges 20–80 - NCT05638854RecruitingPhase 1
Test of ZB002 safety and dosing in rheumatoid arthritis
This early-phase study tests whether ZB002 is safe in people, and how the body handles the drug. It includes both healthy volunteers and people with rheumatoid arthritis (RA) to see if the drug has a predictable blood level pattern.
MelbourneAges 18–70 - NCT05640102Recruiting
Study of zanubrutinib in Waldenström macroglobulinemia
This is an observational study that follows people with Waldenström macroglobulinemia (WM) to learn how well zanubrutinib works and how safe it is. Your results will be tracked in relation to your disease features, including a blood/marrow marker called MYD88.
Huntsville, AlabamaAges 18 years+ - NCT05640752Recruiting
Testing whether better heart imaging planning reduces scans
This trial studies the best way to decide when people need heart imaging tests, with the goal of doing fewer unnecessary scans. It may help patients by avoiding extra radiation and tests while still keeping care safe and appropriate.
Beijing, Beijing MunicipalityAges 30–90 - NCT05641610RecruitingPhase 1/Phase 2
Study drug for adults with hemophilia B who still bleed
This Phase 1/2 study tests ZS801, a gene-related treatment, to see how safe it is and whether it helps prevent bleeding in adults with hemophilia B. You may be considered if you’ve had frequent bleeds or joint problems and meet several lab and health requirements.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05641844Recruiting
Minimally invasive treatment for anal fistulas with a seton
This trial tests whether RD2 Ver.02 is safe and works better than a comparison treatment for treating anal fistulas using a less invasive approach. It may help people who have a seton in place and want to avoid major surgery like flap repair or LIFT.
Los Angeles, CaliforniaAges 18 years+ - NCT05643742RecruitingPhase 1/Phase 2
Study of CTX112 for B-cell cancers that came back or did not respond
This Phase 1/2 study tests how safe and effective CTX112 is for adults whose B-cell cancer has returned or is not responding to treatment. It aims to see whether CTX112 can control the cancer while monitoring side effects closely.
Westwood, KansasAges 18 years+ - NCT05643872RecruitingPhase 3
Test gel QTORIN for adults with pachyonychia congenita
This Phase 3 study tests the safety and how the body absorbs (pharmacokinetics) of a rapamycin gel called QTORIN 3.9% in adults with pachyonychia congenita. It may help determine whether this gel is safe and works for people with this rare skin nail condition.
New Brighton, MinnesotaAges 16 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,384 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.